NVST
Envista Holdings Corp
NYSE · Healthcare · Medical - Equipment & Services · US
$27.28
−1.12%0
Insider buys (3m)
1
Insider sells (3m)
-$220.0K
Net value (3m)
+18.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 27, 2026 | Acurio Veronica · officer: President, Orthodontics | F-InKind | 7,710 | $27 |
| Aug 27, 2026 | Befidi Robert · officer: President, Diagnostics | F-InKind | 5,147 | $27 |
| Aug 27, 2026 | Hammes Eric D. · officer: Chief Financial Officer | F-InKind | 10,885 | $27 |
| Aug 27, 2026 | Nilsson Stefan · officer: President, Nobel Biocare | F-InKind | 804 | $27 |
| Aug 24, 2026 | Reis Mischa · officer: SVP, Strategy & Bus. Dev. | Sale | 8,000 | $28 |
| Aug 20, 2026 | Keel Paul A · director, officer: Chief Executive Officer | A-Award | 159,900 | $0.00 |
| Aug 20, 2026 | Keel Paul A · director, officer: Chief Executive Officer | A-Award | 179,730 | $0.00 |
| Aug 20, 2026 | Hammes Eric D. · officer: Chief Financial Officer | A-Award | 47,970 | $0.00 |
| May 27, 2026 | Keel Paul A · director, officer: Chief Executive Officer | F-InKind | 12,811 | $23 |
| May 21, 2026 | Jain Vivek · director | A-Award | 9,330 | $0.00 |
| May 21, 2026 | Pierce James Andrew · director | A-Award | 9,330 | $0.00 |
| May 21, 2026 | TSINGOS CHRISTINE A · director | A-Award | 9,330 | $0.00 |
| May 21, 2026 | GALLAHUE KIERAN · director | A-Award | 9,330 | $0.00 |
| May 21, 2026 | Raskas Daniel · director | A-Award | 9,330 | $0.00 |
| May 21, 2026 | Huennekens R Scott · director | A-Award | 12,585 | $0.00 |
| May 21, 2026 | Carruthers Wendy · director | A-Award | 9,330 | $0.00 |
| Feb 27, 2026 | Nilsson Stefan · officer: President, Nobel Biocare | F-InKind | 182 | $30 |
| Feb 27, 2026 | Nilsson Stefan · officer: President, Nobel Biocare | A-Award | 7,605 | $0.00 |
| Feb 27, 2026 | Kaabi Faez C · officer: Chief Accounting Officer | F-InKind | 4,964 | $30 |
| Feb 27, 2026 | Befidi Robert · officer: President, Diagnostics | F-InKind | 2,177 | $30 |
| Feb 27, 2026 | Hammes Eric D. · officer: Chief Financial Officer | F-InKind | 2,045 | $30 |
| Feb 27, 2026 | Acurio Veronica · officer: President, Orthodontics | A-Award | 13,845 | $0.00 |
| Feb 27, 2026 | Acurio Veronica · officer: President, Orthodontics | A-Award | 18,020 | $30 |
| Feb 27, 2026 | Hammes Eric D. · officer: Chief Financial Officer | A-Award | 38,040 | $30 |
| Feb 27, 2026 | Befidi Robert · officer: President, Diagnostics | A-Award | 18,020 | $30 |
| Feb 27, 2026 | Hammes Eric D. · officer: Chief Financial Officer | A-Award | 29,225 | $0.00 |
| Feb 27, 2026 | Keel Paul A · director, officer: Chief Executive Officer | A-Award | 115,320 | $30 |
| Feb 27, 2026 | Reis Mischa · officer: SVP, Strategy & Bus. Dev. | A-Award | 14,020 | $30 |
| Feb 27, 2026 | Keel Paul A · director, officer: Chief Executive Officer | F-InKind | 11,840 | $30 |
| Feb 27, 2026 | Befidi Robert · officer: President, Diagnostics | A-Award | 13,845 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 144Increased 279Reduced 251Sold out 56
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 18,437,542 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 17,852,827 | May 13, 2026 |
| ARIEL INVESTMENTS, LLC | Reduced | 10,863,592 | May 14, 2026 |
| ARIEL INVESTMENTS, LLC | Reduced | 9,818,177 | Aug 14, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 9,780,948 | May 7, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Reduced | 9,566,949 | Aug 11, 2026 |
| MORGAN STANLEY | Reduced | 8,793,137 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 7,566,721 | May 8, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Reduced | 7,487,670 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 7,337,916 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 7,318,581 | May 15, 2026 |
| FRANKLIN RESOURCES INC | Reduced | 6,894,025 | May 13, 2026 |
| MORGAN STANLEY | Reduced | 6,436,043 | Aug 13, 2026 |
| Gates Capital Management, Inc. | Increased | 5,552,383 | Aug 14, 2026 |
| GATES CAPITAL MANAGEMENT, INC. | Reduced | 5,362,711 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 27, 2026